In cancer progression, STAT3 mainly promotes oncogenic transcription through well‐established phosphorylation‐dependent pathways, such as the JAK/STAT3 or IL‐6/STAT3 axes, which upregulate cyclin D1, Bcl‐xL and survivin [40]. Here, CCND1 is linked to cancer.